PD-1 inhibition may enhance CD4+ T cell-mediated immune activity8 not only against tumor antigens but also against self-antigens expressed in non-malignant tissues, thereby facilitating increased immune cell infiltration and robust inflammatory responses. The gene discussed is PDCD1; the disease is neoplasm.